Rosty Raykov - Apr 30, 2024 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Rostislav Raykov
Stock symbol
FENC
Transactions as of
Apr 30, 2024
Transactions value $
-$22,152
Form type
4
Date filed
5/2/2024, 04:59 PM
Previous filing
Apr 5, 2024
Next filing
May 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Award $0 +2.43K +1.3% $0.00 190K Apr 30, 2024 Direct F1
transaction FENC Common shares Sale -$22.2K -2.43K -1.28% $9.11 187K May 1, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents release of restriction from shares awarded 3-31-2023
F2 Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023.